These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10837603)

  • 21. Liposomal Delivery Systems: Design Optimization and Current Applications.
    Abu Lila AS; Ishida T
    Biol Pharm Bull; 2017; 40(1):1-10. PubMed ID: 28049940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?
    Fathi S; Oyelere AK
    Future Med Chem; 2016 Nov; 8(17):2091-2112. PubMed ID: 27774793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of liposomal formulations for cell targeting.
    Nogueira E; Gomes AC; Preto A; Cavaco-Paulo A
    Colloids Surf B Biointerfaces; 2015 Dec; 136():514-26. PubMed ID: 26454541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
    Rudokas M; Najlah M; Alhnan MA; Elhissi A
    Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developments in liposomal drug delivery systems.
    Maurer N; Fenske DB; Cullis PR
    Expert Opin Biol Ther; 2001 Nov; 1(6):923-47. PubMed ID: 11728226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in liposome surface modification for oral drug delivery.
    Nguyen TX; Huang L; Gauthier M; Yang G; Wang Q
    Nanomedicine (Lond); 2016 May; 11(9):1169-85. PubMed ID: 27074098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the fate of liposomes in the intestine by dynamic in vitro lipolysis.
    Parmentier J; Thomas N; Müllertz A; Fricker G; Rades T
    Int J Pharm; 2012 Nov; 437(1-2):253-63. PubMed ID: 22939968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent trends in drug delivery systems: liposomal drug delivery system--preparation and characterisation.
    Chandran S; Roy A; Mishra B
    Indian J Exp Biol; 1997 Aug; 35(8):801-9. PubMed ID: 9475051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism and kinetics of the loss of poorly soluble drugs from liposomal carriers studied by a novel flow field-flow fractionation-based drug release-/transfer-assay.
    Hinna AH; Hupfeld S; Kuntsche J; Bauer-Brandl A; Brandl M
    J Control Release; 2016 Jun; 232():228-37. PubMed ID: 27112112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposomal gene delivery mediated by tissue-engineered scaffolds.
    Kulkarni M; Greiser U; O'Brien T; Pandit A
    Trends Biotechnol; 2010 Jan; 28(1):28-36. PubMed ID: 19896228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atomic force microscopy: a tool to study the structure, dynamics and stability of liposomal drug delivery systems.
    Spyratou E; Mourelatou EA; Makropoulou M; Demetzos C
    Expert Opin Drug Deliv; 2009 Mar; 6(3):305-17. PubMed ID: 19327046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposome-targeted delivery for highly potent drugs.
    Bardania H; Tarvirdipour S; Dorkoosh F
    Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1478-1489. PubMed ID: 28278584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barriers to Liposomal Gene Delivery: from Application Site to the Target.
    Saffari M; Moghimi HR; Dass CR
    Iran J Pharm Res; 2016; 15(Suppl):3-17. PubMed ID: 28228799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs.
    Song G; Wu H; Yoshino K; Zamboni WC
    J Liposome Res; 2012 Sep; 22(3):177-92. PubMed ID: 22332871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil.
    Rao M; Alving CR
    Adv Drug Deliv Rev; 2000 Mar; 41(2):171-88. PubMed ID: 10699313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of temoporfin-loaded liposome formulations: correlation of liposome and temoporfin blood concentration.
    Decker C; Schubert H; May S; Fahr A
    J Control Release; 2013 Mar; 166(3):277-85. PubMed ID: 23313962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liposomal nanomedicines: an emerging field.
    Fenske DB; Chonn A; Cullis PR
    Toxicol Pathol; 2008 Jan; 36(1):21-9. PubMed ID: 18337218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding and interstitial penetration of liposomes within avascular tumor spheroids.
    Kostarelos K; Emfietzoglou D; Papakostas A; Yang WH; Ballangrud A; Sgouros G
    Int J Cancer; 2004 Nov; 112(4):713-21. PubMed ID: 15382056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.
    Zylberberg C; Matosevic S
    Drug Deliv; 2016 Nov; 23(9):3319-3329. PubMed ID: 27145899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.